Related Experiment Videos
[Recurrence with gonadic localization of acute leukemia. 113 cases]
Summary
Testicular relapse occurs in 16% of acute lymphoblastic leukemia (ALL) cases, often as the first sign of recurrence. Bilateral testicular irradiation is recommended, alongside intensified systemic therapy to prevent further bone marrow relapse.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Biology
Context:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Relapse is a significant challenge in ALL management.
- Testicular involvement represents a specific pattern of ALL recurrence.
Purpose:
- To determine the incidence and characteristics of testicular recurrences in acute lymphoblastic leukemia (ALL).
- To evaluate the clinical presentation, diagnostic methods, and treatment outcomes for testicular ALL relapse.
- To assess the impact of testicular recurrence on patient survival and identify optimal therapeutic strategies.
Summary:
- A study of 1500 ALL cases revealed a 16% incidence of testicular recurrences (111 cases) and 2 ovarian recurrences.
- Testicular involvement can occur independently or concurrently with bone marrow or meningeal relapse, with 47 cases presenting with testicular tumors as the initial recurrence.
- While most recurrences happen within two years, late gonadal relapses are possible. Isolated testicular recurrence survival averaged 14 months, similar to meningeal relapse.
- Standard chemotherapy and local radiotherapy often led to further recurrence. Bilateral testicular irradiation (2400 rads) is suggested as the optimal local treatment.
- Intensified systemic therapy is crucial due to the high frequency of subsequent bone marrow recurrences.
Impact:
- Highlights the significant incidence of testicular relapse in ALL, emphasizing the need for vigilant monitoring.
- Provides evidence supporting bilateral testicular irradiation as an effective local treatment for ALL recurrence.
- Underscores the necessity of intensified systemic chemotherapy to improve outcomes for patients experiencing testicular relapse.